IDUN Technologies
Internet of Humans: in which our bodies drive, actively and passively, our experiences with connected devices. We have a holistic understanding of all aspects of the value chain from brain activity to product integration. This value chain includes: (1) innovative biosensor development, (2) custom hardware design; (3) data collection and analysis; and (4) product integration. IDUN Technologies integrates neuroscience into every-day product designs, enabling connected devices to understand the emotional needs of people, providing for happier and more fulfilling product experiences. IDUN achieves this by delivering the full neurofeedback value chain from electrode manufacturing to product design integration. This allows the brain waves of person to be comfortably characterized through-out the day to understand their unique emotional needs. Through the IDUN API, actional inputs are sent to connected devices, providing more interactive and fulfilling product experiences. Our goal is to fuse emotion intelligence with connected devices, enabling cohesion and understanding between humans and the connected world. Electroencephalography (EEG) imaging of the brain allows us to characterize the way in which our brain processes information. From EEG signals we extract features related to the emotional and cognitive loads of people. While EEG recording has been used in controlled laboratory environments for decades, it has not been integrated into consumer devices that seamlessly integrate with daily life. We believe that daily measurements of the brain will unlock insights that are not possible with only laboratory measurements. Each brain is unique, with its own algorithm that we are focused on decoding. We translate EEG biomarkers from research findings into our product design and build upon research by developing tests that empirically characterize the brain activity resulting from specific environmental inputs. The goal is to not simply provide the end user with a recording of their brain as a complex data stream, but to give them actionable insights, or passively change their digital experience to better suit their brain state.
Internet of Humans: in which our bodies drive, actively and passively, our experiences with connected devices. We have a holistic understanding of all aspects of the value chain from brain activity to product integration. This value chain includes: (1) innovative biosensor development, (2) custom hardware design; (3) data collection and analysis; and (4) product integration. IDUN Technologies integrates neuroscience into every-day product designs, enabling connected devices to understand the emotional needs of people, providing for happier and more fulfilling product experiences. IDUN achieves this by delivering the full neurofeedback value chain from electrode manufacturing to product design integration. This allows the brain waves of person to be comfortably characterized through-out the day to understand their unique emotional needs. Through the IDUN API, actional inputs are sent to connected devices, providing more interactive and fulfilling product experiences. Our goal is to fuse emotion intelligence with connected devices, enabling cohesion and understanding between humans and the connected world. Electroencephalography (EEG) imaging of the brain allows us to characterize the way in which our brain processes information. From EEG signals we extract features related to the emotional and cognitive loads of people. While EEG recording has been used in controlled laboratory environments for decades, it has not been integrated into consumer devices that seamlessly integrate with daily life. We believe that daily measurements of the brain will unlock insights that are not possible with only laboratory measurements. Each brain is unique, with its own algorithm that we are focused on decoding. We translate EEG biomarkers from research findings into our product design and build upon research by developing tests that empirically characterize the brain activity resulting from specific environmental inputs. The goal is to not simply provide the end user with a recording of their brain as a complex data stream, but to give them actionable insights, or passively change their digital experience to better suit their brain state.
IDUN Technologies has raised $2.2M across 1 round. Its most recent round was a Seed of $2.2M in Sep 2021. Full funding history, investors, and team are detailed below.
Funding history
1 round on record.
Unlock the lead investor and full details for this round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.
IDUN Technologies is featured in
Similar companies
arcoris bio provides spatial multiomics solutions focused on transforming biomedical research and diagnostics.
HemostOD manufactures platelets on-demand from engineered stem cells.
DropGen focuses on cutting-edge lab technology that enables the precise control of very small droplets within patterned microarrays.
Pharvaris is a clinical-stage company working on bringing a new oral bradykinin B2 receptor antagonist to patients as an alternative to injected therapies for hereditary angioedema and other related conditions. Their lead drug candidate, PHA121, is a potent small-molecule bradykinin B2 receptor antagonist currently in Phase 1 clinical study. The co-founders of Pharvaris include the inventor of icatibant and key leaders from Jerini AG, who developed icatibant for HAE treatment, now marketed as Firazyr® by Takeda.
Sequana Medical is a Swiss medical device company providing implantable pump systems to manage fluid balance within the body. This system is designed to move excess fluid to the bladder, where it is passed naturally from the body through normal urination. Sequana Medical’s first product, the Alfapump System, is an innovative solution for the management of ascites. Ascites is a fluid that collects in the abdominal cavity in people with advanced liver disease, certain cancers, or congestive heart failure. Alfapump System was the first and only system for the automatic and continual removal of ascites. Sequana Medical was founded in 2006 and is based in Zurich, Switzerland.
A Swiss medical technology business called Medyria develops systems for endovascular catheter navigation and sensing. The goal of Medyria is to speed up, secure, and improve catheter-based treatments. In Technopark in Winterthur, Switzerland, Medyria is headquartered.
SEITO Biologics is a new biotechnology startup in the preclinical stage, focused on developing creative immunotherapies for autoimmune and chronic inflammatory conditions.
ReproNovo is changing the landscape of reproductive medicine and women's health by pushing boundaries and introducing cutting-edge treatments for infertility and uterine conditions such as adenomyosis. Our experienced international team is well-versed in reproductive medicine, drug development, regulatory strategy, and business development, with a successful history of bringing new therapies to the market. Backed by top investors, including Jeito Capital and M Ventures, our headquarters are in Lausanne, Switzerland, with development teams in Copenhagen, Denmark and Barcelona, Spain. Contact us at info@repronovo.com for more information. Meet our leadership team: CEO & Co-Founder Jean Duvall, Chief Scientific & Medical Officer & Co-Founder Joan-Carles Arce, and Chief Financial Officer & Co-Founder BingMei Hao.
HAYA Therapeutics is a company that develops RNA-based treatments for heart failure. Their therapies target a specific regulator of fibrosis in the heart, known as long noncoding RNA, in order to block myocardial fibrosis and effectively treat heart failure.
Granite Bio is a biotechnology company working on creating new antibodies for the treatment of inflammatory, autoimmune, and fibrotic diseases.
MoonLake Immunotherapeutics is a biopharmaceutical company in the clinical stage that is developing new therapies and harnessing the potential of Sonelokimab, a novel investigational Nanobody®, to transform results for patients experiencing inflammation.
SamanTree Medical is a pioneering medical device company from Switzerland that offers an innovative imaging solution that has the potential to enhance patient care and improve the results of cancer surgery. Their solution, which is based on confocal microscopy, allows surgeons to have precise and comprehensive control over margins during surgery.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.